|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Blue_Belt_Technologies
gptkb:Tissue_Regenix_Group
Osiris Therapeutics
|
|
gptkbp:advertising
|
various executives
|
|
gptkbp:awards
|
various industry awards
|
|
gptkbp:ceo
|
gptkb:Roland_Diggelmann
|
|
gptkbp:conducts_research_on
|
various executives
|
|
gptkbp:employees
|
around 18,000
|
|
gptkbp:founded
|
1856
|
|
gptkbp:founder
|
Thomas Smith
|
|
gptkbp:global_presence
|
over 100 countries
|
|
gptkbp:has_authority_over
|
various executives
|
|
gptkbp:head
|
various executives
|
|
gptkbp:head_of_state
|
various executives
|
|
gptkbp:headquarters
|
gptkb:London,_United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Smith & Nephew
|
|
gptkbp:industry
|
gptkb:medical_devices
|
|
gptkbp:invention
|
numerous medical device patents
|
|
gptkbp:market_position
|
leading in advanced wound care
leading in orthopedic devices
leading in sports medicine
|
|
gptkbp:partnership
|
NHS (National Health Service)
various hospitals worldwide
|
|
gptkbp:products
|
sports medicine
endoscopy
wound management
orthopedic reconstruction
|
|
gptkbp:regulatory_compliance
|
various executives
|
|
gptkbp:research_and_development
|
clinical studies
product enhancements
medical technology innovations
|
|
gptkbp:revenue
|
$5 billion (2020)
|
|
gptkbp:social_responsibility
|
gptkb:healthcare_access
education initiatives
disaster relief efforts
|
|
gptkbp:stock_exchange
|
gptkb:London_Stock_Exchange
|
|
gptkbp:stock_symbol
|
SN.
|
|
gptkbp:subsidiaries
|
gptkb:Smith_&_Nephew_Healthcare_Ltd.
gptkb:Smith_&_Nephew_Inc.
|
|
gptkbp:supply_chain
|
various executives
|
|
gptkbp:sustainability_initiatives
|
community engagement
ethical sourcing
environmental responsibility
|
|
gptkbp:website
|
www.smith-nephew.com
|
|
gptkbp:bfsParent
|
gptkb:urban_park
|
|
gptkbp:bfsLayer
|
4
|